| 000 | 01799 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514233619.0 | ||
| 264 | 0 | _c20060103 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0931-041X | ||
| 024 | 7 |
_a10.1007/s00467-005-1983-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFujinaga, Shuichiro | |
| 245 | 0 | 0 |
_aInduction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children. _h[electronic resource] |
| 260 |
_bPediatric nephrology (Berlin, Germany) _cOct 2005 |
||
| 300 |
_a1500-3 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aKidney _xpathology |
| 650 | 0 | 4 |
_aLupus Nephritis _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylprednisolone _xtherapeutic use |
| 650 | 0 | 4 |
_aPrednisolone _xadministration & dosage |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aRibonucleosides _xadministration & dosage |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 700 | 1 | _aKaneko, Kazunari | |
| 700 | 1 | _aOhtomo, Yoshiyuki | |
| 700 | 1 | _aMurakami, Hitohiko | |
| 700 | 1 | _aTakada, Masaru | |
| 700 | 1 | _aAkashi, Shunji | |
| 700 | 1 | _aHira, Mayako | |
| 700 | 1 | _aYamashiro, Yuichiro | |
| 773 | 0 |
_tPediatric nephrology (Berlin, Germany) _gvol. 20 _gno. 10 _gp. 1500-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00467-005-1983-9 _zAvailable from publisher's website |
| 999 |
_c15676746 _d15676746 |
||